Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pluristem Therapeutics Inc.

www.pluristem.com

Latest From Pluristem Therapeutics Inc.

Pipeline Watch: Phase III Progress With BL-8040, Recorlev And Estelle

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

 

Pipeline Watch Approvals

Pipeline Watch Phase III Progress With Trintellix, Ocrevus And Olumiant

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Execs On The Move, May 2017

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Appointments BioPharmaceutical

Appointments: Crescendo, Shield, Sarepta, Verona, Hansa, Astellas and Pluristem

This week’s roundup includes various high-level appointments by companies including Vencerx Therapeutics, which has elected a new CEO, Shield Therapeutics, Crescendo Biologics, Pluristem Therapeutics, Sarepta Therapeutics and Verona Pharma.

Appointments BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Inflammation
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Pluristem Life Systems Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Middle East
      • Israel
  • Parent & Subsidiaries
  • Pluristem Therapeutics Inc.
  • Senior Management
  • Yaky Yanay, Pres. & CEO
    Chen Franco-Yehuda, CFO
    Racheli Ofir, PhD, VP, Rsch. & IP
    Lior Raviv, VP, Dev.
    Dan Peres, MD, VP, Clinical & Medical Affairs
  • Contact Info
  • Pluristem Therapeutics Inc.
    Phone: (972) 74-710-8600
    MATAM Advanced Tech. Park
    Bldg #5
    Haifa, 31905
    Israel
Advertisement
Advertisement
UsernamePublicRestriction

Register